Learn More
Medchemexpress LLC Enlicitide (chloride) | 2407527-16-4 | 99.6% | 1586.29 | 500 UG

Supplier: Medchemexpress LLC HYP4153500UG
Enlicitide chloride is an orally active PCSK9 inhibitor with an IC50 of 2.5 nM. It blocks the interaction between the LPL receptor and PCSK9, increasing LPL receptor levels and ultimately decreasing low-density lipoprotein cholesterol (LDL-C) levels. It is used in the study of cardiovascular diseases such as atherosclerosis and hypercholesterolemia.
- Orally active PCSK9 inhibitor
- Blocks interaction between LPL receptor and PCSK9
- Increases LPL receptor levels
- Decreases low-density lipoprotein cholesterol (LDL-C) levels
- Suitable for cardiovascular disease research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.